Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Thorax. 2021 Jul 12;77(1):13–21. doi: 10.1136/thoraxjnl-2021-217158

Table 3.

Clinical outcomes in the primary cohorts stratified by ARDS subphenotypes.

Ventilator-Free Days In-hospital mortality*
Hypo-inflammatory Hyper-inflammatory P-value Hypo-inflammatory Hyper-inflammatory P-value
VALID AECC 20 (11 – 25) 5 (0 – 20) < 0.0001 80/457 (18%) 87/167 (52%) < 0.0001
VALID AECC (NO TRAUMA) 21 (8 – 25) 4 (0 – 18) < 0.0001 71/315 (23%) 80/137 (58%) < 0.0001
EARLI AECC 24 (0 – 28) 0 (0 – 23) < 0.0001 62/211 (29%) 75/124 (60%) < 0.0001

P- value represent Wilcoxon rank sum test for ventilator free days and chi-squared test for in hospital mortality. AECC = American-European Consensus Conference.

*

Followed up to day 60 in EARLI and to discharge in VALID